biospecimen__admin__batch_number	203.73.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	CAC1DBDE-E96E-4863-A7AF-9DE942C2530F
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-A3CJ-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-A3CJ-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-A3CJ-01A
biospecimen__bio__biospecimen_barcode_bottom	0122967829
biospecimen__bio__day_of_creation	07
biospecimen__bio__day_of_shipment	24
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	10
biospecimen__bio__month_of_shipment	01
biospecimen__bio__pathology_report_file_name	TCGA-G3-A3CJ.191868C4-3299-4E65-9DB2-C8C43CB83963.pdf
biospecimen__bio__plate_column	11
biospecimen__bio__plate_id	A214
biospecimen__bio__plate_row	A
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-G3-A3CJ
biospecimen__shared__patient_id	A3CJ
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	801473E2-D72B-4D8B-9408-7E2F1D374BBF
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	0.3
clinical__chol_lihc_shared__albumin_result_specified_value	0.4
clinical__chol_lihc_shared__albumin_result_upper_limit	0.5
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.5
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.8
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	3
clinical__chol_lihc_shared__fibrosis_ishak_score	5 - Nodular Formation and Incomplete Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis C
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	52
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-A3CJ-F40234
clinical__clin_shared__bcr_followup_uuid	ACE37AC4-FA90-4FAA-80CD-DB0ABAAA35C0
clinical__clin_shared__day_of_form_completion	17
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	2
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	185
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Severe
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	296
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Lung
clinical__nte__new_neoplasm_event_type	Extrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rad__anatomic_treatment_site	Distant site
clinical__rad__bcr_radiation_barcode	TCGA-G3-A3CJ-R40238
clinical__rad__bcr_radiation_uuid	12767A64-5DF8-480E-A1D5-54FDFE1F1EDD
clinical__rad__days_to_radiation_therapy_start	559
clinical__rad__radiation_treatment_ongoing	YES
clinical__rad__radiation_type	External
clinical__rx__bcr_drug_barcode	TCGA-G3-A3CJ-D40237
clinical__rx__bcr_drug_uuid	2579D68E-1CDC-4AB5-8F3B-E366F68B5152
clinical__rx__days_to_drug_therapy_end	367
clinical__rx__days_to_drug_therapy_start	346
clinical__rx__drug_name	Sorafenib
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Targeted Molecular therapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	74d20c07-732b-4574-a21d-95e18b5a2405
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-A3CJ-01A-11R-A214-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	5eea4961-cde1-4c65-b185-19fe22f29694
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.77
gdc__analytes__analyte_id	d905ea25-ebb5-413b-98ee-bcd34f1af8e4
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	cb8f3c76-da86-4a1d-977c-44ab399b342a
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	547a4a84-4f6b-5a32-899f-5d866e736284
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	american indian or alaska native
gdc__demographic__year_of_birth	1959
gdc__diagnoses__age_at_diagnosis	19305
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-19305.0
gdc__diagnoses__days_to_last_follow_up	594.0
gdc__diagnoses__diagnosis_id	91a50186-51bc-56b3-909d-c6358ca63be1
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	23.781212841854934
gdc__exposures__exposure_id	59251913-6089-5eca-aef3-21e002e9fe52
gdc__exposures__height	174.0
gdc__exposures__weight	72.0
gdc__file_id	945142e3-0559-423d-87e9-07dd47d61b1a
gdc__file_name	849d7c70-bab7-481c-8eb9-084268a5a197.mirbase21.mirnas.quantification.txt
gdc__file_size	50207
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	e66c2d0e760226016df898b27f7438ab
gdc__portions__is_ffpe	false
gdc__portions__portion_id	3fe1e5d6-4bb1-4fd6-a08f-37be6c0b2845
gdc__portions__portion_number	11
gdc__portions__weight	20.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	113
gdc__samples__initial_weight	20.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	191868C4-3299-4E65-9DB2-C8C43CB83963
gdc__samples__sample_id	a8ab7daf-079d-458b-ad09-a99306384864
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	93.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	fbe46e1e-3ca9-4968-bd56-3edb27488d5c
gdc__submitter_id	mirna_swap_dr11_379_MirnaExpressiondfc2616f-4c9c-41d5-81d8-36e705ca1cdb_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	1e4318ab-281e-5d03-956a-dae3562b6649
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:20.705+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/74d20c07-732b-4574-a21d-95e18b5a2405-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/74d20c07-732b-4574-a21d-95e18b5a2405-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129578
manually_curated__local_md5	6c4f82d4fe6352a0f4836e81cea442b9
manually_curated__opengdc_download_date	2018-10-16T17:12:14.000015+02:00
manually_curated__opengdc_file_md5	af2a35e76d35f72b2aee0c0569680ee9
manually_curated__opengdc_file_size	50206
manually_curated__opengdc_id	74d20c07-732b-4574-a21d-95e18b5a2405-meq
manually_curated__origin_file_size	129578
manually_curated__origin_last_modified_date	Tue Oct 16 17:30:00 CEST 2018
manually_curated__origin_md5	6c4f82d4fe6352a0f4836e81cea442b9
manually_curated__tissue_status	tumoral
